Free Account Opening + AMC Free Demat
Loading...

Austral IPO vs Chemcel Biotech IPO

Comparision between Austral IPO and Chemcel Biotech IPO.

IPO Details

Austral IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Chemcel Biotech IPO is a Mainline Fixed Price Issue proposed to list at BSE.

  Austral IPO Chemcel Biotech IPO
Logo Austral IPO Logo Chemcel Biotech IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Fixed Price Issue
Listing At BSE, NSE BSE
Lead Managers Allahabad Bank

Saffron Capital Advisors Private Limited
Allahabad Bank
Registrar Link Intime India Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Austral IPO is up to ₹142.30 Cr whereas the issue size of the Chemcel Biotech IPO is up to ₹24.64 Cr. The final issue price of Austral IPO is ₹196.00 per share and of Chemcel Biotech IPO is ₹16.00 per share.

  Austral IPO Chemcel Biotech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹164.00 per share
Issue Price (Upper) ₹196.00 per share
Issue Price (Final) ₹196.00 per share ₹16.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 34 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 72,60,000 shares 1,54,00,000 shares
Issue Size Total (Amount) up to ₹142.30 Cr up to ₹24.64 Cr

IPO Timetable

Austral IPO opens on Aug 07, 2008, while Chemcel Biotech IPO opens on Sep 09, 2008. The closing date of Austral IPO and Chemcel Biotech IPO is Aug 13, 2008, and Sep 12, 2008, respectively.

  Austral IPO Chemcel Biotech IPO
Anchor Bid Date
Issue Open Aug 07, 2008 Sep 09, 2008
Issue Close Aug 13, 2008 Sep 12, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Austral IPO P/E ratio is , as compared to Chemcel Biotech IPO P/E ratio of .

  Austral IPO Chemcel Biotech IPO
Financial
ParticularsFor the year/period ended (Rs. in Lacs)
  29-Feb-0831-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income27395.0419030.6912811.114321.972031.96
  Profit After Tax (PAT)3517.25914.79202.07127.7430.51
ParticularsFor the year/period ended (Rs. in Lacs)
  30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income61.172347.662180.081223.811337.96
  Profit After Tax (PAT)10.3793.6275.6818.398.41
Promoter Shareholding (Pre-Issue) 87.41% 57.23%
Promoter Shareholding (Post-Issue) 65.56% 29.4%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 10.85%% 9.14%%

Shares Offered

In the Austral IPO retail investors (RII) are offered while in Chemcel Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Austral IPO and in Chemcel Biotech IPO.

  Austral IPO Chemcel Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Austral IPO subscribed 1.65x in total, whereas Chemcel Biotech IPO subscribed .

  Austral IPO Chemcel Biotech IPO
QIB (times) 0.62x
NII (times) 7.32x
Big NII (times)
Small NII (times)
RII (times) 0.69x
Employee (times)
Other (times)
Total (times) 1.65x

Comments

Add a public comment...